Breaking news

Mall Of Cyprus And Mall Of Engomi Join Ablebook Platform

The Ablebook application has announced its new partnership with the Mall of Cyprus and the Mall of Engomi, integrating their spaces into its platform.

This partnership aims to facilitate access and provide information for people with disabilities and other vulnerable groups, a relevant press release notes.

Ablebook, an application on Android and iOS devices, aims to improve accessibility and support people with disabilities and other vulnerable groups by offering information and services that facilitate their daily lives.

As noted in the press release, the Mall of Cyprus and the Mall of Engomi offer a range of accessible infrastructure, such as dedicated parking spaces near the entrances, ramps, accessible toilets and comfortable wheelchair spaces.

“Through this partnership, Ablebook users visiting the specific malls can be informed about the accessible facilities and ask for assistance, if needed, from the relevant mall staff. This ensures that all visitors can enjoy their shopping experience and moments without obstacles,” the press release adds.

“Our collaboration with the Mall of Cyprus and Mall of Engomi is another step towards a more equal and open society for all. By offering facilities and services that cater to the needs of people with disabilities, shopping centers contribute positively to social progress and solidarity,” Ablebook’s announcement concludes.

Medochemie And Theramir Announce Strategic Investment Agreement To Advance Biotech Manufacturing In Cyprus

Pharmaceutical manufacturer Medochemie and biotechnology company Theramir, both Cyprus-based, have announced a strategic investment agreement and collaboration aimed at developing next-generation biological therapies and expanding manufacturing capabilities in Cyprus.

The agreement, announced on 2 September 2026, brings together Medochemie’s experience in pharmaceutical manufacturing and Theramir’s biotechnology research. The companies said the collaboration would support advanced pharmaceutical manufacturing in Cyprus and south-eastern Europe.

What The Partnership Covers

Medochemie’s contribution will include its expertise in manufacturing sterile therapeutic products and its access to international markets.

Theramir develops technologies based on extracellular vesicles and microRNAs. Its work includes using stem-cell-derived extracellular vesicles to deliver microRNAs, small, non-coding RNA molecules that regulate genes and biological pathways associated with cancer growth and metastasis.

Under the agreement, the companies will jointly support the development of “Good Manufacturing Practice” capabilities for next-generation biological therapies. The partnership is also intended to help move these therapies towards clinical development.

A Wider Role For Cyprus

The collaboration will also support Theramir’s wider research programme. According to the companies, it is intended to strengthen Cyprus’s biotechnology infrastructure and expand local capacity in next-generation biomanufacturing.

They present the agreement as a step towards giving Cyprus a larger role in biotechnology and advanced pharmaceutical manufacturing for south-eastern Europe and international markets.

eCredo
Aretilaw firm
The Future Forbes Realty Global Properties
Uol

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter